Skip to content
Live funding
↑Microbiotica €42.7M Series C round led by British Business Bank ↑Goodweek €10.7M funding round led by Adara Ventures ↑Qilimanjaro Quantum Tech €19.6M raises a Series A round ↑Ambio €5.1M Seed round led by Lifeline Ventures ↑Duvo €28.5M Series A round led by Balderton Capital ↑Salience Labs €111.4M Series B round led by Bullhound Capital ↑Wavo €10M funding round led by Eurazeo ↑Cofrai €2.6M funding round led by DFF Ventures ↑Undecimal Bio €16M Seed round led by 4BIO Capital ↑Obsero €1M Seed round led by SFC Capital ↑ParkMundo €2.3M Seed round led by Rabobank ↑Ubitium €12.5M Seed round led by Ibex Investors ↑Alchera Technologies €3.2M Seed round led by Maven Capital Partners ↑Sainaptic €1.2M funding round led by Brighteye Ventures ↑reebuild €3M Seed round led by Rise PropTech ↑Causa Prima €17.9M Seed round led by Base10 Partners ↑Affinity Labs €1.8M Pre-seed round led by Antler ↑Epyr €15M Series A round led by SlateVC ↑CarbonFarm €7M Series A round led by Colam Impact ↑CMR Surgical €358.1M funding round led by Stryker
Sesame Summit 2027
Sesamers

TeiaCare raises €7 million to scale AI-powered care monitoring across Europe

Also see more funding coverage: /funding/

Round at a glance
€7MGrowth Announced 9 April 2026
Founded 2018 · Italy
CompanyTeiaCare · profile
HQItaly
SectorAI
StageGrowth
Lead P101 SGR
Team 38 people
Participants Namarel Inderhabs existing shareholders

Europe’s ageing population is placing unprecedented strain on residential care infrastructure, with demand for intelligent monitoring solutions accelerating as facilities struggle to balance operational efficiency with quality of care. Italian healthtech startup TeiaCare has secured €7 million in fresh funding to expand its AI-powered care monitoring platform across new European markets and into broader healthcare settings.

The investment, led by returning backer P101 SGR with participation from existing shareholders and new investors including Spanish family offices Namarel and Inderhabs, will fund TeiaCare’s international expansion into France and Spain whilst supporting the development of advanced Data, Spatial, and Care Intelligence capabilities.

P101 SGR leads expansion-stage investment

P101 SGR, one of Italy’s most active venture capital firms, led the round as a returning investor, signalling continued confidence in TeiaCare’s growth trajectory. The participation of Namarel and Inderhabs, both Spanish family offices, is strategically significant as it coincides with TeiaCare’s planned entry into the Spanish market alongside France.

Founded in 2018 by Guido Magrin and Luca Iozzia, TeiaCare has developed Ancelia, a proprietary platform that combines optical sensors and artificial intelligence to monitor care environments in real time. The system generates actionable insights for care staff in nursing homes, rehabilitation centres, and dementia care units, enabling faster response times and more informed clinical decision-making without intrusive wearable devices.

The company has built considerable traction across Italy, serving more than 150 clients across over 200 facilities and covering approximately 75,000 residents. This footprint, concentrated across key Italian regions including Lombardy, Emilia-Romagna, Veneto, and Tuscany, provides a solid foundation for the planned European expansion.

European care technology market gains momentum

The investment comes at a time when European governments are increasingly recognising the need for technology-driven solutions in eldercare. With the continent’s over-65 population projected to reach 130 million by 2050, the pressure on residential care facilities to deliver better outcomes with constrained resources is only intensifying.

TeiaCare’s approach — using ambient optical sensors rather than wearable devices — addresses a critical adoption barrier in care settings, where residents may resist or be unable to use wearable technology. The non-invasive nature of the Ancelia platform has been a key differentiator in securing facility-level adoption across Italy.

Beyond its core residential care market, TeiaCare plans to extend its solutions into broader healthcare and home care settings, potentially opening significantly larger addressable markets. The development of Spatial Intelligence and Care Intelligence modules suggests the company is building toward a comprehensive data platform for care environments, rather than remaining a point solution for monitoring.

The €7 million round positions TeiaCare to compete in a European healthtech landscape that has seen growing investor interest in AI-powered care solutions, as demographic pressures and workforce shortages make technology adoption in care settings not merely desirable but essential.

For more startup fundraising news and insights into Europe’s innovation ecosystem, explore our coverage of the latest funding rounds.

Summary

Company TeiaCare
HQ Italy
Founded 2018
Founders Guido Magrin, Luca Iozzia
Round Growth
Amount €7 million
Lead Investor P101 SGR
Other Investors Namarel, Inderhabs
Use of Funds European expansion (France, Spain), platform development, broader healthcare settings
Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.